Dermatology NewsPyzchiva Receives FDA Approval as Third Ustekinumab BiosimilarJuly 2, 2024Psoriatic ArthritisPediatricsRare DiseasesPsoriasis
Dermatology NewsPsoriatic Arthritis Symptoms Relieved with TYK2 Inhibitor in Phase 2 TrialJune 28, 2024Psoriatic Arthritis
Dermatology NewsPsoriatic Arthritis Drug Candidate Sonelokimab Yields Significant Improvements in Phase 2 TrialJune 28, 2024Psoriatic Arthritis
Dermatology NewsFDA Proposes that Interchangeability Status for Biosimilars Doesn’t Need Switching StudiesJune 28, 2024Business of MedicineMixed Topics
Commentary: Topical Treatments for AD and Possible Lifestyle Adjustments, July 2024June 28, 2024Atopic Dermatitis
Frequent or Severe Flares Linked to Increased Atopic Dermatitis Severity June 27, 2024Atopic Dermatitis
Frequent or Severe Flares Linked to Increased Atopic Dermatitis Severity June 27, 2024Atopic Dermatitis
Study Shows Bidirectional Association Between Polycystic Ovary Syndrome and Atopic DermatitisJune 27, 2024Atopic Dermatitis
Maintenance Optimization in Abrocitinib Induction Responders With Atopic DermatitisJune 27, 2024Atopic Dermatitis
High Prevalence of Overweight or Obesity in Children With Atopic DermatitisJune 27, 2024Atopic Dermatitis
Tapinarof Effective and Well-Tolerated in Adults and Children With Atopic DermatitisJune 27, 2024Atopic Dermatitis
Tapinarof Effective and Well-Tolerated in Adults and Children With Atopic DermatitisJune 27, 2024Atopic Dermatitis
